Skip to main content
editor@jprims.in
9343055451
e-ISSN: 3049-1681
Journal of Pharmaceutical Research and Integrated Medical Sciences

Journal of Pharmaceutical Research and Integrated Medical Sciences

Published

Ethanolic Leaf Extract of Chenopodium album Linn. Attenuates Calcium Oxalate-Associated Urolithiasis in Rats: An Integrated In Vitro and In Vivo Evaluation

Published in JPRIMS, Vol-3, Issue-11, November-2026 (Vol. 3, Issue 11, 2026)

Ethanolic Leaf Extract of Chenopodium album Linn. Attenuates Calcium Oxalate-Associated Urolithiasis in Rats: An Integrated In Vitro and In Vivo Evaluation - Issue cover

Abstract

Background: The primary stone component in urolithiasis, a recurrent urinary tract disease characterized by crystal nucleation, development, aggregation, and retention, is calcium oxalate (CaOx). Chenopodium album Linn. has a long history of ethnomedical use for urinary and renal issues and has demonstrated an initial anti-crystallization effect. However, little information is known about the relationship between in vivo renal and urinary outcomes and in vitro CaOx crystallization. Objective: This study evaluated the anti-urolithiatic potential of an ethanolic leaf extract of C. album (EECA) using complementary in vitro and in vivo techniques. Methods: The leaves were subjected to Soxhlet extraction using ethanol to obtain a 6.0% w/w extract, and preliminary phytochemical screening was carried out. The nucleation of CaOx was measured at 10–100 mg/mL, and the inhibition of crystal growth was also examined. The standard treatment was cystone (750 mg/kg). EECA was given at doses of 50 and 200 mg/kg to rats with urolithiasis associated with calcium oxalate. Urinary uric acid, urine volume, and renal histology were determined. Results: EECA inhibited CaOx nucleation in a concentration-dependent manner by 18.75% at 10 mg/mL and 77.50% at 100 mg/mL. Inhibition at 100 mg/mL exceeded the observed Cystone response of 72.50%. EECA also raised urine production and reduced urinary uric acid, particularly at 200 mg/kg. The results of the histopathology showed improved kidney structure. Conclusion: EECA demonstrated anti-crystallization and protective qualities in experimental urolithiasis, encouraging further mechanistic, phytochemical-standardizing, and translational research.

Citations & discovery

Explore citations to this article and find it in scholarly databases.

Crossref
…
Citations
View record
Europe PMC
…
DOI matches
View results
Google Scholar

Checking citation sources…

Citation counts reflect each source's coverage. Europe PMC shows DOI search matches, including mentions in references. Article lists may be incomplete. Google Scholar opens a separate search.

Authors (3)

Arpan Kumar Tripathi

Kamla Institute of Pharmaceuti...

View all publications →

Yashika

Kamla Institute of Pharmaceuti...

View all publications →

Deleshwar Kumar

Kamla Institute of Pharmaceuti...

View all publications →

Download Article

PDF

Best for printing and citation

File size: 1.9 MB
Format: PDF

Summarise this paper with AI:

Article Information

JPRIMS1130002

JPRIMS-01-000310

27-40

2026-11-17

JATS XML

Article Impact

Views:1,197
Downloads:1,528
scite_
PlumX Metrics Badge

How to Cite

Kumar Tripathi, A., Yashika, & Kumar, D. (2026). Ethanolic Leaf Extract of Chenopodium album Linn. Attenuates Calcium Oxalate-Associated Urolithiasis in Rats: An Integrated In Vitro and In Vivo Evaluation. Journal of Pharmaceutical Research and Integrated Medical Sciences, 3(11), 27-40. https://doi.org/10.64063/3049-1681.vol3.issue11.000310

Article Actions